CSafe Global opens new service centers in Switzerland and Sweden to meet what it says is “soaring demand” for CSafe active containers across Europe.
CSafe, a global provider active temperature-controlled container solutions for the pharmaceutical industry, has expanded its cold chain service offerings in Europe by opening two new technical service centres – one at Zurich Airport (ZRH) in Switzerland and one at the Stockholm Arlanda Airport (ARN) in Sweden.
The addition of these new European service centres will strengthen the existing CSafe service centre network within the EU. CSafe says this will ensure that the organisation “is well positioned to optimally serve the higher volume of inbound and outbound traffic of the innovative CSafe RKN and CSafe RAP active temperature-controlled containers in the European region.”
The new Swiss and Swedish service centre facilities will ensure that CSafe’s active containers are operating at peak system performance, keeping temperatures precisely where they need to be for vital shipments of pharmaceuticals as they are transported to patients around the world, the company says.
“As part of our continuing commitment to deliver value, effective, and quality temperature-sensitive shipping solutions to our customers across Europe, we opened the ZRH and ARN service centers to support the increasing demand for CSafe containers.
“We are certainly proud of CSafe’s unprecedented growth and the expansion of our active container fleet by almost 100 per cent over the past 24 months, states Tom Weir, VP of Global Operations at CSafe.
“We have more than enough capacity with our active fleet to continue with our accelerated growth strategy to expand geographically and serve our global customers with the most innovative temperature-controlled containers available”.
CSafe service centers are key to ensuring that the company’s active temperature-controlled container systems maintain the high operational standards expected for meeting the critical needs of its life-science customers and partners across the globe.
“The new Zurich and Stockholm service centres will further strengthen CSafe’s commitment to deliver on its promise of protecting what matters most to pharmaceutical companies, so patients can receive what matters most to them,” CSafe adds.